Judge chose four plaintiff experts in upcoming Xarelto trial

Honorable Judge Eldon E. Fallon recently chose four experts as witnesses during the upcoming Xarelto trial that has been scheduled for April 24, 2017. Defendants Bayer and Janssen tried to exclude them from providing testimony on behalf of the almost 17,000 plaintiffs...

Xarelto first bellwether trial pushed to April 2017

The first Xarelto bellwether trial has been pushed by another month and is now scheduled to begin in April 2017. This is the third time both parties agree to reschedule the four trials which are now set to begin in April, May, June and July. Last time the trial was...

Woman files Abilify Lawsuit after becoming a gambling addict

A woman from Colorado recently filed a lawsuit claiming that she developed an unmanageable gambling addiction that ruined her life after she started Abilify treatment. As reported by The Daily Beast, Lucy started taking her medication shortly after she had to witness...

Invokana Lawsuits have been centralized in the MDL No. 2750

After a large number of plaintiffs had filed an Invokana lawsuit the Judicial Panel on Multidistrict Litigation (JPML) centralized 55 cases in a new Multidistrict Litigation (MDL). To speed up proceedings and help the attorneys efficiently coordinate trials, testimony...

New study sheds light on IVC filters’ dangerousness

A new study sheds light on the Inferior Vena Cava (IVC) filters' alleged dangerousness, further substantiating the allegations of those who recently filed a lawsuit. The research was published in the Journal of the American Medical Association Surgery on January...

Total Taxotere lawsuits grew three-fold in 2017

The largest ongoing litigation in 2017 seems to be the Taxotere lawsuit, as the number of cases filed tripled in just two months. According to data from the Judicial Panel on Multidistrict Litigation (JPML), as of January 17, 2017, the total number of disputes filed...

Eliquis Mass Tort centralization scheduled for January

On January 26, the U.S. Judicial Panel on Multidistrict Litigation (JPML) will hear arguments regarding the centralization of several Eliquis lawsuits under a new MDL in Miami, Florida. The drug's manufacturers Bristol-Myers Squibb and Pfizer Inc. filed a motion to...

Study reaffirms Xarelto’s safety but the litigation keeps growing

A new analysis published by manufacturers Janssen Pharmaceutical and Bayer AG shows that the Novel Oral Anticoagulant (NOAC) Xarelto (rivaroxaban) is safer and less expensive than its competitors in patients affected by cancer. The research that was presented at the...